Total Payments
$1,800
2024 Payments
$503.36
Companies
27
Transactions
107
Medicare Patients
715
Medicare Billing
$62,476
Payment Breakdown by Category
Food & Beverage$1,800 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,800 | 107 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $692.77 | 46 | $0 (2024) |
| Novo Nordisk Inc | $223.89 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $69.80 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $68.88 | 5 | $0 (2022) |
| Lilly USA, LLC | $51.18 | 3 | $0 (2024) |
| Exact Sciences Corporation | $49.63 | 3 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $49.11 | 3 | $0 (2024) |
| Abbott Laboratories | $48.82 | 2 | $0 (2021) |
| Alkermes, Inc. | $46.99 | 2 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $46.91 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $503.36 | 31 | ABBVIE INC. ($244.63) |
| 2023 | $529.01 | 34 | AbbVie Inc. ($290.67) |
| 2022 | $403.58 | 22 | ABBVIE INC. ($84.04) |
| 2021 | $325.40 | 18 | AbbVie Inc. ($73.43) |
| 2020 | $38.66 | 2 | Allergan, Inc. ($38.66) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Obesity | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Oncology | ||||||
| 09/27/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $24.42 | General |
| 09/27/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Neuropsychiatry | ||||||
| 08/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Respiratory | ||||||
| 07/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Respiratory | ||||||
| 05/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Obesity | ||||||
| 05/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Endocrinology | ||||||
| 04/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PENBRAYA | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: VACCINES | ||||||
| 04/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.89 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 191 | 249 | $70,227 | $19,821 |
| 2022 | 5 | 158 | 206 | $45,788 | $14,713 |
| 2021 | 6 | 199 | 256 | $40,670 | $17,649 |
| 2020 | 6 | 167 | 207 | $32,422 | $10,293 |
Total Patients
715
Total Services
918
Medicare Billing
$62,476
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 126 | $38,627 | $9,976 | 25.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 53 | 53 | $16,548 | $6,375 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 31 | $6,731 | $1,567 | 23.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 18 | $6,953 | $1,295 | 18.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $1,368 | $606.90 | 44.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 115 | $29,773 | $7,916 | 26.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 32 | 32 | $8,288 | $3,921 | 47.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 26 | $4,841 | $1,321 | 27.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 16 | 16 | $1,902 | $1,097 | 57.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 17 | 17 | $984.48 | $458.83 | 46.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 109 | $24,784 | $9,345 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 23 | 23 | $5,089 | $2,933 | 57.6% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 53 | 53 | $2,650 | $1,942 | 73.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 26 | $4,131 | $1,633 | 39.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 22 | 22 | $2,593 | $1,436 | 55.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 23 | 23 | $1,423 | $359.49 | 25.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 72 | 104 | $22,618 | $6,427 | 28.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 14 | 14 | $3,579 | $1,535 | 42.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 29 | $4,143 | $1,312 | 31.7% |
| 90653 | Vaccine for influenza for injection into muscle | Office | 2020 | 12 | 12 | $880.22 | $714.36 | 81.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 13 | 13 | $677.00 | $201.53 | 29.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 31 | 35 | $525.00 | $102.90 | 19.6% |
About Dr. Melinda Cooper, MD
Dr. Melinda Cooper, MD is a Pediatrics healthcare provider based in Morgantown, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1134339427.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melinda Cooper, MD has received a total of $1,800 in payments from pharmaceutical and medical device companies, with $503.36 received in 2024. These payments were reported across 107 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,800).
As a Medicare-enrolled provider, Cooper has provided services to 715 Medicare beneficiaries, totaling 918 services with total Medicare billing of $62,476. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Morgantown, WV
- Active Since 05/23/2007
- Last Updated 06/24/2021
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1134339427
Products in Payments
- VRAYLAR (Drug) $330.53
- UBRELVY (Drug) $315.47
- Rybelsus (Drug) $108.66
- Ozempic (Drug) $57.81
- Wegovy (Drug) $57.42
- SOLIQUA 100/33 (Biological) $51.32
- Cologuard Collection Kit (Device) $49.63
- INGREZZA (Drug) $49.11
- FreeStyle Libre (Device) $48.82
- ARISTADA (Drug) $46.99
- ELIQUIS (Drug) $46.91
- NURTEC ODT (Drug) $41.22
- LINZESS (Drug) $40.51
- SHINGRIX (Biological) $38.06
- CAPLYTA (Drug) $37.33
- JARDIANCE (Drug) $36.86
- AIRSUPRA (Drug) $35.48
- Otezla (Drug) $30.55
- Dexcom G6 Transmitter (Medical Supply) $29.32
- VIBERZI (Drug) $25.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Morgantown
Christy Glass, Pnp, PNP
Pediatrics — Payments: $14,040
Pediatrics $14,040
Dr. Kathryn Moffett, M.d, M.D
Pediatrics — Payments: $7,827
Pediatrics $7,827
Dr. Melissa Albert, M.d, M.D
Pediatrics — Payments: $4,725
Pediatrics $4,725
Lap-Yang Li, M.d, M.D
Pediatrics — Payments: $1,722
Pediatrics $1,722
Alyssa Barnette, Pnp, PNP
Pediatrics — Payments: $1,241
Pediatrics $1,241
Jessica Oliverio, Pnp, PNP
Pediatrics — Payments: $1,238
Pediatrics $1,238